#420: Cannabis – Kevin Boehnke, PhD & Carrie Cuttler, PhD

Sigma Nutrition Radio

Danny Lennon

Sigma, Dietetics, Evidencebased, Nutrition, Training, Health & Fitness, Science, Diet, Fitness, Evidence, Bodybuilding, Health

4.8 • 626 Ratings

🗓️ 4 January 2022

⏱️ 81 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Kevin Boehnke is a researcher at the University of Michigan, in the Chronic Pain and Fatigue Research Center. His current research focuses on therapeutic applications of illicit or semi-licit substances (cannabis, psychedelics). His goal is to rigorously assess appropriate use of these substances and to help address the public health harms caused by their criminalization.

Carrie Cuttler is an Assistant Professor at Washington State University. Her research at the Health and Cognition Laboratory there focuses on elucidating the potentially beneficial and detrimental effects of chronic cannabis use and acute cannabis intoxication. Her recent work has focused on examining links between cannabis use and mental health (e.g., ADHD, PTSD, OCD, depression, anxiety).

Show notes available at sigmanutrition.com/episode420/

Transcript

Click on a timestamp to play from that location

0:00.0	Hello and welcome to Sigmat Nutrition Radio. My name is Danny Lennon and you are listening to Episode 420 of the podcast.
0:23.7	And in keeping with this being episode 420, what better topic to discuss than cannabis?
0:30.4	We're going to be talking about cannabis and human health today, particularly focusing in on
0:35.6	research going into various interventions to determine whether
0:39.7	we can have therapeutic benefit from cannabis or any of the isolated cannabinoids.
0:45.2	And there's a lot of hype in this area.
0:48.5	There's a lot of discussion going on.
0:50.1	There's, of course, a lot of people already using this in a therapeutic sense, whether that's
0:55.9	through prescription or otherwise. And there is good reason to believe that there may be some
1:02.6	potential here. However, we then want to say, okay, what does the evidence base actually tell us?
1:07.5	What do we have from clear human trials of these interventions?
1:12.6	What are potentially some of the risks? And how do we weigh all this stuff up to put that into
1:16.5	evidence-based recommendations going forward? So of course, there's a lot that we could discuss
1:21.6	around the topic of cannabis and health. We're going to focus in on two particular areas.
1:26.7	And these seem to be the two main areas
1:29.1	that people will turn to cannabis in a therapeutic sense to help treat something.
1:36.7	So this would particularly relate to, number one, the use of cannabis as an intervention in chronic
1:42.4	pain. And then secondly, the use of cannabis for a
1:45.8	variety of mental health or mood-related disorders. So whether that's anxiety, depression, ADHD,
1:53.2	PTSD, OCD, all of these have associations with potential for cannabis use. And there have been a number of trials looking at this
2:03.0	to see whether cannabis or cannabinoids have a role. And so this particular episode is a bonus
2:08.7	episode of sorts given that you're getting two interviews. So I'm going to be talking to two
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Danny Lennon, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Danny Lennon and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.